Comparison of the efficacy of high dose and conventional dose of budesonide/formoterol inhalation in stable COPD
10.3969/j.issn.1005-1678.2017.04.074
- VernacularTitle:大剂量与常规剂量布地奈德/福莫特罗粉吸入剂治疗COPD稳定期的疗效对比
- Author:
Yifei JIANG
;
Xiang GE
;
Meng YANG
- Keywords:
budesonide/formoterol;
stable COPD;
pulmonary function;
adverse reaction
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(4):226-228
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare large dose or conventional dose of budesonide/formoterol fumarate powder in treatment of stable chronic obstructive pulmonary disease(COPD).Methods 120 patients with stable COPD from March 2015 to March 2016 in Jiaxing Second hospital were selected,were treated with budesonide/formoterol,and were divided into the conventional dose group and high dose groupaccording to different doses,60 cases in each group.Pulmonary function tests,CAT Chinese version scale assessment and 6 min walking distance(6MWD)test were performed before and after treatment,and adverse reactions and acute attack were observed.Results FEV1/FVC and FEV1％were significantly improved after treatment in the two groups,and those in the high dose group were significantly better than those in the conventional dose group,the difference was statistically significant(P<0.05),CAT score and 6MWD were significantly improved after treatment in the two groups,and those in the high dose group were significantly higher than those in the conventional dose group,the difference was statistically significant(P<0.05),adverse reactions such as palpitations,tachycardiain the high dose group were significantly higher than those in the conventional dose group,while the acute attack rate was significantly lower than that of the conventional dose group,the difference was statistically significant(P<0.05).Conclusion High dose of budesonide/formoterol inhalation in the treatment of patients with stable COPD powder can improve the pulmonary function and health status,but adverse reactions increase.
